Eagle Strategies LLC

Position in NVS — Novartis AG

CIK 1907666 NEW YORK, NY

Position in NVS

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$409,979

+$8,247 QoQ

Shares Held

2,616

-0.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#980

of 1,603 holders

Holding Since

Dec 2021

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eagle Strategies LLC holds $8,022,452 across 6 Drug Manufacturers - General names. NVS ranks #4 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	4,271	$5,122,765
2	JNJ	Johnson & Johnson	3,678	$934,101
3	ABBV	AbbVie Inc.	3,262	$820,849
4	NVS	Novartis AG This page	2,616	$409,979
5	GILD	Gilead Sciences, Inc.	3,232	$408,330
6	PFE	Pfizer Inc	13,556	$326,428

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$409,979	2,616	-0.5%	Shares	Sole	2026-07-21
2026-03-31	$401,732	2,630	+1.0%	Shares	Sole	2026-04-20
2025-12-31	$358,875	2,603	0.0%	Shares	Sole	2026-01-23
2025-09-30	$333,808	2,603	0.0%	Shares	Sole	2025-10-21
2025-06-30	$314,989	2,603	+1.3%	Shares	Sole	2025-07-23
2025-03-31	$286,503	2,570	0.0%	Shares	Sole	2025-04-23
2024-12-31	$250,086	2,570	0.0%	Shares	Sole	2025-02-14
2024-09-30	$295,601	2,570	0.0%	Shares	Sole	2024-10-25
2024-06-30	$273,602	2,570	+1.4%	Shares	Sole	2024-08-08
2023-12-31	$255,857	2,534	0.0%	Shares	Sole	2024-01-26
2023-09-30	$258,113	2,534	0.0%	Shares	Sole	2023-11-08
2023-06-30	$255,705	2,534	0.0%	Shares	Sole	2023-08-03
2023-03-31	$233,128	2,534	+1.2%	Shares	Sole	2023-04-24
2022-12-31	$227,253	2,505	-1.5%	Shares	Sole	2023-02-06
2022-06-30	$215,044	2,544	-1.2%	Shares	Sole	2022-08-10
2022-03-31	$225,868	2,574	+2.0%	Shares	Sole	2022-05-02
2021-12-31	$220,774	2,524	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.